Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
2.
Angew Chem Int Ed Engl ; 48(10): 1827-9, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19173267

RESUMEN

The quaternary king: Azithromycin (1), which has improved pharmacological profiles compared with erythromycins, was the target of an enantioselective synthesis. All the stereogenic quaternary carbon centers were elaborated by a desymmetrization of 2-substituted glycerols using a chiral imine/CuCl(2) catalyst.


Asunto(s)
Antibacterianos/síntesis química , Azitromicina/síntesis química , Antibacterianos/química , Azitromicina/química , Catálisis , Cobre/química , Eritromicina/química , Iminas/química , Estereoisomerismo
3.
ACS Med Chem Lett ; 3(8): 678-82, 2012 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-24900529

RESUMEN

We identified a novel class of aryl-substituted triazine compounds as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) during a high-throughput screening campaign that evaluated more than 200000 compounds for antihuman immunodeficiency virus (HIV) activity using a cell-based full replication assay. Herein, we disclose the optimization of the antiviral activity in a cell-based assay system leading to the discovery of compound 27, which possessed excellent potency against wild-type HIV-1 (EC50 = 0.2 nM) as well as viruses bearing Y181C and K103N resistance mutations in the reverse transcriptase gene. The X-ray crystal structure of compound 27 complexed with wild-type reverse transcriptase confirmed the mode of action of this novel class of NNRTIs. Introduction of a chloro functional group in the pyrazole moiety dramatically improved hERG and CYP inhibition profiles, yielding highly promising leads for further development.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA